Literature DB >> 29618137

Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.

David Taïeb1, Henri Timmers2, Karel Pacak3.   

Abstract

The mitochondrial enzyme succinate dehydrogenase (SDH) acts as a tumor suppressor. Biallelic inactivation of one of the genes encoding for SDH subunits (collectively named SDHx) leads to complete loss of the protein function and the development of diverse group of tumors. Pheochromocytomas-paragangliomas are the prime example of hereditary tumors caused by SDH deficiency. In this review, we discuss the roles of imaging examinations, and illustrate new insights into genotype-imaging phenotype relationships. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29618137      PMCID： PMC7444674          DOI： 10.1055/a-0586-3710

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


  32 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Ingo Janssen; Elise M Blanchet; Karen Adams; Clara C Chen; Corina M Millo; Peter Herscovitch; David Taieb; Electron Kebebew; Hendrik Lehnert; Antonio T Fojo; Karel Pacak
Journal:  Clin Cancer Res       Date:  2015-04-14       Impact factor: 12.531

3.  Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.

Authors:  Florian Haller; Evgeny A Moskalev; Fabio R Faucz; Sarah Barthelmeß; Stefan Wiemann; Matthias Bieg; Guillaume Assie; Jerome Bertherat; Inga-Marie Schaefer; Claudia Otto; Eleanor Rattenberry; Eamonn R Maher; Philipp Ströbel; Martin Werner; J Aidan Carney; Arndt Hartmann; Constantine A Stratakis; Abbas Agaimy
Journal:  Endocr Relat Cancer       Date:  2014-05-23       Impact factor: 5.678

4.  Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.

Authors:  Eleni Daniel; Robert Jones; Matthew Bull; John Newell-Price
Journal:  Eur J Endocrinol       Date:  2016-09-15       Impact factor: 6.664

5.  Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Authors:  Lauren Fishbein; Ignaty Leshchiner; Vonn Walter; Ludmila Danilova; A Gordon Robertson; Amy R Johnson; Tara M Lichtenberg; Bradley A Murray; Hans K Ghayee; Tobias Else; Shiyun Ling; Stuart R Jefferys; Aguirre A de Cubas; Brandon Wenz; Esther Korpershoek; Antonio L Amelio; Liza Makowski; W Kimryn Rathmell; Anne-Paule Gimenez-Roqueplo; Thomas J Giordano; Sylvia L Asa; Arthur S Tischler; Karel Pacak; Katherine L Nathanson; Matthew D Wilkerson
Journal:  Cancer Cell       Date:  2017-02-02       Impact factor: 31.743

6.  Head-to-head comparison between 18F-FDOPA PET/CT and MR/CT angiography in clinically recurrent head and neck paragangliomas.

Authors:  Céline Heimburger; Francis Veillon; David Taïeb; Bernard Goichot; Sophie Riehm; Julie Petit-Thomas; Gerlinde Averous; Marcela Cavalcanti; Fabrice Hubelé; Gerard Chabrier; Izzie Jacques Namer; Anne Charpiot; Alessio Imperiale
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-03       Impact factor: 9.236

Review 7.  New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.

Authors:  David Taïeb; Karel Pacak
Journal:  Trends Endocrinol Metab       Date:  2017-08-31       Impact factor: 12.015

8.  In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Bellucci; Aurélie Morin; Alexandre Buffet; Laurence Amar; Maxime Janin; Chris Ottolenghi; Franck Zinzindohoué; Gwennhael Autret; Nelly Burnichon; Estelle Robidel; Benjamin Banting; Sébastien Fontaine; Charles-André Cuenod; Paule Benit; Pierre Rustin; Philippe Halimi; Laure Fournier; Anne-Paule Gimenez-Roqueplo; Judith Favier; Bertrand Tavitian
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

9.  Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.

Authors:  Roland Därr; Joan Nambuba; Jaydira Del Rivero; Ingo Janssen; Maria Merino; Milena Todorovic; Bela Balint; Ivana Jochmanova; Josef T Prchal; Ronald M Lechan; Arthur S Tischler; Vera Popovic; Dragana Miljic; Karen T Adams; F Ryan Prall; Alexander Ling; Meredith R Golomb; Michael Ferguson; Naris Nilubol; Clara C Chen; Emily Chew; David Taïeb; Constantine A Stratakis; Tito Fojo; Chunzhang Yang; Electron Kebebew; Zhengping Zhuang; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2016-09-27       Impact factor: 5.678

10.  Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.

Authors:  Xianmin Mu; Ting Zhao; Che Xu; Wei Shi; Biao Geng; Jiajia Shen; Chen Zhang; Jinshun Pan; Jing Yang; Shi Hu; Yuanfang Lv; Hao Wen; Qiang You
Journal:  Oncotarget       Date:  2017-02-21
View more
  1 in total

Review 1.  Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance.

Authors:  Jan Calissendorff; Carl Christofer Juhlin; Irina Bancos; Henrik Falhammar
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.